Page-2 of SPUTNIK V
Why is GoI fast tracking the Emergency use of foreign made COVID-19 Vaccines?
The Government of India recently announced that it is speeding up the Emergency Usage Approvals of foreign made COVID-19 vaccines. This includes COVID-19 vaccines that have been granted Emergency Use Authorisation (EUA) in other countries. Role of NEGVAC in the ..
Month: Current Affairs - April, 2021
India: Expert panel recommends approval to Sputnik V vaccine
An Expert panel of the Central Drugs Standard Control Organisation (CDSCO) recently approved the Emergency Use of COVID-19 vaccine Sputnik-V. However, the Drugs Controller General of India (DGCI) is to take a final call on the recommendation. When approved, Sputnik ..
Month: Current Affairs - April, 2021
What is Carnivac-Cov Vaccine?
The first animal vaccine against the novel coronavirus in the world has been registered in Russia. It was announced by the country’s agriculture safety watchdog Rosselkhoznadzor. Key Points The world’s first animal vaccine against the novel coronavirus has been named ..
Month: Current Affairs - April, 2021
India approved two COVID-19 vaccines for Emergency Use
The Drug Controller General of India recently announced that it has authorised two COVID-19 vaccines for restricted Emergency Use in India. What are the two COVID-19 Vaccines approved by DGCI for emergency use? COVAXIN and COVISHIELD What is COVAXIN? The ..
Month: Current Affairs - January, 2021
COVAXIN of Bharat Biotech enters Phase III trials: Largest COVID-19 clinical trial of India
On November 16, 2020 the Bharat Biotech announced the commencement of Phase III trials of COVAXIN vaccines in India. The trials will involve 26,000 volunteers. It is to be held in partnership with the Indian Council of Medical Research. The ..
Month: Current Affairs - November, 2020
Mission COVID Suraksha: Key Facts
On November 12, 2020, the Finance Minister Nirmala Sitharaman announced Mission COVID Suraksha. Under the mission, the Government of India has allocated Rs 900 crores to the research and development of COVID-19 vaccines in India. The funds allocated do not ..